Biohacking and Longevity Tech Boom: CGMs, Women's Health, and Consumer Wellness Trends in 2026 cover art

Biohacking and Longevity Tech Boom: CGMs, Women's Health, and Consumer Wellness Trends in 2026

Biohacking and Longevity Tech Boom: CGMs, Women's Health, and Consumer Wellness Trends in 2026

Listen for free

View show details

About this listen

 In the past 48 hours, the biohacking industry shows steady momentum in longevity tech, with no major market disruptions but growing consumer interest in women's health and non-prescription devices.[1] The overlapping longevity market hit 21.3 billion dollars in 2024 and is projected to reach 63 billion by 2035, per Market Research Future, while women's health diagnostics stand at 49.3 billion in 2024, eyeing 68.5 billion by 2030.[1]

Key developments include Dexcom's partnership with influencer Glucose Goddess Jesse Inchauspé to launch Stelo, the first over-the-counter continuous glucose monitor for non-diabetics, tapping biohacking trends long popular among enthusiasts.[4] This move by a major medical device firm signals Big Wellness invading regulated medicine, raising concerns over non-diabetic use.[4] Meanwhile, Levels Health Core CGM 2026 gains traction, with Europeans like those in Spain using import services to bypass credit card hurdles and shipping costs.[8]

Consumer behavior shifts toward accessible hacks: a 24-year-old at a San Francisco biohacking event tested IV drips, red light therapy, and neurofeedback, praising some for performance boosts but noting limitations in real results.[2] In supplements, biohackers in India and New Zealand pivot from US brands like Momentous Magnesium Threonate to local high-purity options amid supply chain tweaks.[5]

Emerging competitors focus regionally, like Middle East panels at MedTech World Dubai 2026 on biohacking and regenerative devices, fueled by rapid longevity demand.[6] No new regulatory changes or price drops surfaced in the last week, but leaders like Dexcom respond to challenges by blending medtech with wellness influencers, contrasting slower prior medical-only approaches.[4]

Compared to earlier 2026 reports, activity feels niche versus explosive, with events and imports highlighting grassroots adoption over blockbuster deals. Overall, biohacking thrives on personalization, not volatility. (Word count: 298)

For great deals today, check out https://amzn.to/44ci4hQ

This content was created in partnership and with the help of Artificial Intelligence AI

This episode includes AI-generated content.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.